LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation

Oncotarget
Chia-Huei LeePinpin Lin

Abstract

Previously, we identified global epigenetic aberrations in smoking-associated oral squamous cell carcinoma (OSCC). We hypothesized that cigarette exposure triggers OSCC through alteration of the methylome of oral cells. Here we report that cigarette smoke condensate (CSC) significantly changes the genomic 5-methyldeoxycytidine content and nuclear accumulation of DNA methyltransferase 1 (DNMT1) and DNMT3A in human untransformed oral cells. By using integrated analysis of cDNA and methylation arrays of the smoking-associated dysplastic oral cell line and OSCC tumors, respectively, we identified four epigenetic targets--UCHL1, GPX3, LXN, and LDOC1--which may be silenced by cigarette. Results of quantitative methylation-specific PCR showed that among these four genes, LDOC1 promoter was the most sensitive to CSC. LDOC1 promoter hypermethylation and gene silencing followed 3 weeks of CSC treatment. LDOC1 knockdown led to a proliferative response and acquired clonogenicity of untransformed oral cells. Immunohistochemistry showed that LDOC1 was downregulated in 53.3% (8/15) and 57.1% (20/35) of premalignant oral tissues and early stage OSCCs, respectively, whereas 76.5% (13/17) of normal oral tissues showed high LDOC1 expression. Furt...Continue Reading

References

Dec 1, 1977·Journal of the National Cancer Institute·S GrahamS Fischman
Dec 2, 1992·International Journal of Cancer. Journal International Du Cancer·S E ChangW E Marnock
May 16, 2000·Cell Biology and Toxicology·G J HammonsB D Lyn-Cook
Nov 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A BhattacharjeeM Meyerson
Apr 25, 2003·International Journal of Cancer. Journal International Du Cancer·Koichi NagasakiNicolai Maass
Nov 22, 2005·Lancet·Goodarz DanaeiUNKNOWN Comparative Risk Assessment collaborating group (Cancers)
Dec 5, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ruo-Kai LinYi-Ching Wang
Apr 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·José M Mato, Shelly C Lu
Jul 4, 2007·Mayo Clinic Proceedings·Deepak Kademani
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Sara GandiniPeter Boyle
Oct 3, 2009·The European Respiratory Journal·C-K WangP Lin
Apr 5, 2011·American Journal of Human Genetics·Lutz P BreitlingHermann Brenner
Sep 13, 2012·Experimental and Therapeutic Medicine·Yao LiuWenchao Liu
Oct 16, 2013·Cancer Investigation·Marie-Luise BuchholtzAnsgar Brüning
May 31, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Curtis R PickeringJeffrey N Myers

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE54861

Methods Mentioned

BETA
enzyme-linked immunoassay
biopsies
PCR
ELISA
Assay

Software Mentioned

Methyl Primer Expression
GeneSpring GX
MetaMorph

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Kyoung Ah KangJin Won Hyun
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
B-J ZhaoX Ma
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
K HibiA Nakao
© 2021 Meta ULC. All rights reserved